BPC-157 + TB-500

What Should You Know?

• Treatment description using appropriate regulatory language.
• Explanation that both peptides are investigational.
• Individual medical evaluation before treatment.

Possible Side Effects

• Injection site irritation or redness
• Headache
• Dizziness
• Nausea
• Fatigue
• Other mild symptoms
• Pregnancy and breastfeeding warning
• Patients with significant medical conditions should consult our medical team before treatment.

Key Information

• Investigational peptide combination.
• Being studied for its possible role in tissue recovery and regenerative pathways.
• Under investigation for its potential to support muscles, tendons, ligaments, jointsand mobility.
• Requires medical evaluation and ongoing follow-up.

Important

• BPC-157 and TB-500 are investigational peptides.
• Not approved by the U.S. Food and Drug Administration (FDA).
• Safety and effectiveness continue to be evaluated.
• BPC-157 and TB-500 are prohibited by the World Anti-Doping Agency (WADA) forathletes subject to its regulations.
• Adults 18 years of age or older only.